Abstract submission is closed. The abstract deadline was 17 July 2020

Researchers from all over the world are welcome to submit their abstracts and help shape the virtual program of COLDA 2020. Delegates with accepted abstracts will experience a dynamic and interactive virtual meeting. Make use of this unique opportunity to share your knowledge and research on a wide spectrum of topics related to liver disease. 

If you are planning to submit an abstract, we advise you not to register until the status of your abstract is known. Delegates with accepted abstracts will receive complimentary registration. 

Abstracts can be submitted either in English or French. 

Categories for Abstract Submission

For purposes of review and programming, abstracts were divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. Abstracts will be accepted either for oral or poster presentation. 

Please see the categories for abstract submission below:

  • Viral Hepatitis Infections (Elimination / Prevention / Treatment / Clinical)
  • Hepatitis Coinfections
  • Non-Viral Hepatitis-Related Infections
  • Non-Infectious Induced Liver Disease
  • Hepatocellular Carcinoma (HCC)
  • Liver Cirrhosis / End-Stage Liver Disease
  • Pediatric Liver Disease
  • Alcoholic Liver Disease
  • Metabolic Liver Disease Including NASH
  • Diagnostics and Investigation
  • Community Experience
  • Interactive Clinical Cases

General Guidelines 

Abstracts should contain the following four components:

  • Background: A concise statement of the issue under investigation or a hypothesis
  • Materials and Methods: The experimental methods used (including the statistical analyses employed)
  • Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable)
  • Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable)

Please note: Abstracts cannot be accepted if tables, graphs, grant acknowledgments, or literature references are included.

The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For abstracts that are accepted, submitters agree to attend the virtual meeting and present their abstract as scheduled.

 Abstract Submission

Abstract submission is open. 

Young Investigators/Post-Doctoral/MD

We are pleased to offer free registration to young investigators with an accepted abstract and a 50% discount on the registration fee for young investigators without an accepted abstract.

IMPORTANT: Free registration is offered to the presenting author of the abstract only.

Applicants should:

  • Be 35 years of age or younger
  • Be a current Master/PharmD/PhD student OR
  • Have obtained an MD/PharmD/PhD degree in the last five years

An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the conference. Please click the following link to download the form: Young Investigators Form

Virology Education will contact the young investigator with instructions regarding registration for the conference once the application has been received.

Notification of Abstract Acceptance and Presentation Format

It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Notifications of acceptance and format of presentation (oral or poster presentation) will be announced in August 2020. Please notify the conference secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract Publication

Accepted abstracts will be published in the Abstract Book. All abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typographic or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.